Stem cell therapy takes advantage of the special healing quality of stem cells. These cells can help repair damaged tissues in the body. Stem cells are found in your bone marrow. The Sports Medicine physicians at The Orthopaedic Center specialize in both BMAC and PRP treatments.
Bone Marrow Aspirate Concentrate (BMAC) treatment, also known as Bone Marrow Concentrate (BMC) treatment is a non-surgical regenerative treatment for various orthopedic injuries, including moderate to severe osteoarthritis and tendon injures. BMAC is a concentrate of regenerative stem cells obtained from the patients own bone marrow. The physician removes a small amount of the patients bone marrow and uses it to generate a powerful concentrate that is injected into the treatment area.
Unlike other cells of the body, bone marrow cells are undifferentiated, which means they have the ability to transform themselves into a variety of tissue types. When injury occurs, the quantity of regenerative cells needed for tissue regeneration may be inadequate. With BMAC, the injection of regenerative cells provides a more robust healing of damaged tissue and aids in growth and repair by accelerating the bodys natural healing mechanism. While the full benefits of BMAC are still unknown, BMAC has been shown to reduce swelling, relieve pain, and enhance healing of articular cartilage and bone.
Numerous conditions can be considered for treatment with BMAC. Currently, moderate to severe osteoarthritis and severe tendon injuries show promising results.
Knee Osteoarthritis is currently the best indication. Others are listed below.
In general, PRP may be more appropriate for mild to moderate osteoarthritis or tendon injuries. BMAC may be reserved for more challenging cases such as moderate to severe osteoarthritis or when more potent effects are desired.
With the patient sedated, the bone marrow aspiration site is locally numbed so minimal pain is felt. Bone marrow is removed from the back of the pelvis (hip) at the posterior iliac crest. The concentration of bone marrow (stem cells and healing components), also known as the bone marrow aspirate concentrate (BMAC), is injected into the treatment area. Patients go home the same day.
Unlike cortisone/steroid shots which simply mask symptoms (and may damage tissue with repeated injections), BMAC targets the root of the problem and attempts to heal the tissue.
Most patients require only a single BMAC treatment. However, if a patient experiences significant relief that plateaus, they may consider a second BMAC injection months later.
For the first 2-3 days, swelling and discomfort may occur in the injected area. By the end of the first week, these symptoms usually begin to resolve. Physical therapy is started within a few days of the treatment, to optimize BMAC effects and facilitate recovery. Patients respond to BMAC treatment along varying timelines.
Bone marrow derived cancer (such as lymphoma) and active systemic infection are contra-indications. Other types of cancer may be a contra-indication and approval must be obtained from the patients oncologist.
No. While there is evidence showing the positive effects of BMAC treatment on tendon, soft tissue, and cartilage injuries, BMAC is not covered by insurance companies at this time.
Most patients notice some level of improvement by 2-6 weeks following their BMAC treatment. Increases in stability and strength are typically reported, along with the decreases in pain. A second level of benefit may be obtained between 6 weeks and 3 months following BMAC. Patients should remain active with a physical therapy program and strengthen surrounding muscles during this period.
Platelet-Rich Plasma (PRP) is produced from your own blood. Platelets are cells in our body that contain growth factors. These growth factors stimulate the normal wound healing process, such as when your skin heals after a scrape. For PRP treatments, we concentrate your platelets (to over 5x more platelets than your normal blood) and deliver them to the area of interest, to help heal injured tissue. Some PRP treatments are done under ultrasound guidance to confirm placement of the PRP in the correct tissue.
PRP is indicated for injuries that have failed to heal despite traditional treatments. PRP treatments can be performed in any musculoskeletal structure, including muscles, tendons, joints and ligaments. Some examples include: partial tendon tears, muscle strains, ligament sprains/partial tears, articular cartilage injury, and chronic tendon injuries.
To prepare PRP, blood is taken from your arm with a special kit. This is similar to a normal blood draw. The blood is then placed in a centrifuge that separates the platelets from the blood, creating the PRP. The entire PRP treatment process takes about 45 minutes.
Many patients achieve successful outcomes with only one treatment, especially for soft-tissue problems. In some cases, a series of three treatments is required to achieve significant results. This is particularly true for joint treatments. Each treatment is spaced several weeks apart. There is no limit to the number of treatments you can have; however, if youre not seeing significant improvement after three treatments, you should consider other forms of treatment.
Since your own blood is used, there is no risk for transmitted blood-infections. PRP has a strong antibacterial effect so the risk of local infection is minimal. It is possible to have increased soreness or pain for several days after the treatment. You may be prescribed pain medication to help with this.
PRP treatment is a fairly new procedure, and most insurance companies have not incorporated it yet to their list of approved procedures and do not consider it a reimbursable expense. PRP treatment fees include the PRP kit, blood draw, use of centrifugation machine, disposable equipment, ultrasound guidance (if needed), and the actual procedure. A splint for support may be indicated in some cases (additional fee, likely with some insurance coverage).
PRP stimulates healing of the injured tissue by activating your bodys natural healing potential. On average, patients report more than 50% improvement at 6 weeks and up to 100% improvement at 12 weeks after treatment. PRP treatment may eliminate the need for other treatments such as long-term medication or surgery.
Excerpt from:
Regenerative Medicine | Stem Cell Therapy | Huntsville AL
- Advances in regenerative medicine-based approaches for skin ... - March 9th, 2025
- Regenerative Medicine: Case Study for Understanding and Anticipating ... - March 9th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 9th, 2025
- Editorial: Tissue Engineering and Regenerative Medicine: Advances, Controversies, and Future Directions by Frontiers in Bioengineering and... - March 9th, 2025
- Malaysia To Host 7th World Conference On Exercise And Regenerative Medicine - BERNAMA - March 9th, 2025
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 9th, 2025
- Worlds First 3D-Printed Penis Implant Successfully Restores Function in Pigs and Rabbits - The Daily Galaxy --Great Discoveries Channel - March 9th, 2025
- AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinsons disease investigational gene therapy - Bayer - February 24th, 2025
- What is Regenerative Medicine? | Regenerative Medicine | University of ... - February 24th, 2025
- The quest for a communication device that tells cells to regenerate the body - Big Think - February 24th, 2025
- Transforming the future of regenerative medicine - Reuters - February 24th, 2025
- Breakthrough Alzheimer's Treatment Gets Official WHO Recognition - Major Milestone for Rare Disease Therapy - StockTitan - February 24th, 2025
- Regenerative Medicine Pioneer with 35-Year Track Record Takes Scientific Helm at ZEO ScientifiX - StockTitan - February 24th, 2025
- 101 Guide to Regenerative Medicine Types | Applications, Challenges - February 7th, 2025
- Regenerative Medicine | What is it? | ASCPM - February 7th, 2025
- Regenerative medicine and advanced therapy | NIST - February 7th, 2025
- Therapeutic Reprogramming toward Regenerative Medicine - February 7th, 2025
- Novel living biomaterial aims to advance regenerative medicine - February 7th, 2025
- UC Irvine-led discovery of new skeletal tissue advances regenerative ... - February 7th, 2025
- Top 3 Grants in Regenerative Medicine: January 2025 - RegMedNet - February 7th, 2025
- Advancements in lung regeneration: from bench to bedside - February 7th, 2025
- Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized... - February 7th, 2025
- Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location -... - February 7th, 2025
- Cell therapy weekly: iPSC therapy IND for Phase III trial cleared - RegMedNet - February 7th, 2025
- Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz - EIN News - February 7th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 7th, 2025
- Stem Cells Applications in Regenerative Medicine and Disease ... - December 6th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 6th, 2024
- Master of Science in Regenerative Medicine and Entrepreneurships FUSION program information session - The Daily | Case Western Reserve University - December 6th, 2024
- BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire - December 6th, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 6th, 2024
- University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness - University of... - December 6th, 2024
- Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug... - December 6th, 2024
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023